BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31096450)

  • 1. Differences of bleedings after percutaneous coronary intervention using femoral closure and radial compression devices.
    Kim SH; Behnes M; Baron S; Shchetynska-Marinova T; Tekinsoy M; Mashayekhi K; Hoffmann U; Borggrefe M; Akin I
    Medicine (Baltimore); 2019 May; 98(20):e15501. PubMed ID: 31096450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of femoral closure compared to radial compression devices following percutaneous coronary intervention: the FERARI study.
    Fastner C; Behnes M; Ünsal M; El-Battrawy I; Ansari U; Mashayekhi K; Hoffmann U; Lang S; Kuschyk J; Borggrefe M; Akin I
    Heart Vessels; 2017 May; 32(5):520-530. PubMed ID: 27803954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extravascular compared to Intravascular Femoral Closure is Associated with Less Bleeding and Similar MACE after Percutaneous Coronary Intervention.
    Kim SH; Behnes M; Baron S; Shchetynska-Marinova T; Uensal M; Mashayekhi K; Hoffmann U; Borggrefe M; Akin I
    Int J Med Sci; 2019; 16(1):43-50. PubMed ID: 30662327
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective randomised comparison of minor bleedings in transradial vs. transfemoral access percutaneous coronary interventions for STEMI: a new FEMORAL bleeding classification.
    Kołtowski L; Filipiak KJ; Tomaniak M; Kochman J; Pietrasik A; Rdzanek A; Huczek Z; Scibisz A; Mazurek T; Opolski G
    Kardiol Pol; 2014; 72(9):790-7. PubMed ID: 24846364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial access-site complications after use of a vascular closure device related to puncture height.
    Sartorius B; Behnes M; Ünsal M; Hoffmann U; Lang S; Mashayekhi K; Borggrefe M; Akin I
    BMC Cardiovasc Disord; 2017 Feb; 17(1):64. PubMed ID: 28209184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of radial access versus femoral access with the use of a vascular closure device for the prevention of vascular complications and mortality after percutaneous coronary intervention.
    Téblick A; Vanderbruggen W; Vandendriessche T; Bosmans J; Haine SEF; Miljoen H; Segers V; Wouters K; Vrints C; Claeys MJ
    Acta Cardiol; 2018 Jun; 73(3):241-247. PubMed ID: 28851255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between Radial Approach and Femoral Approach With Vascular Closure Devices on the Occurrence of Access-Site Complications and Periprocedural Bleeding After Percutaneous Coronary Procedures: A Systematic Review and Meta-Analysis.
    Rigattieri S; Sciahbasi A; Ratib K; Alonzo A; Cox N; Chodór P; Berni A; Fedele S; Pugliese FR; Cooper CJ; Louvard Y; Nolan J; Rao SV
    J Invasive Cardiol; 2016 Dec; 28(12):473-479. PubMed ID: 27630147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
    Andrade PB; Mattos LA; Rinaldi FS; Bienert IC; Barbosa RA; Labrunie A; Tebet M; Esteves V; Abizaid A; Sousa AR
    Catheter Cardiovasc Interv; 2017 May; 89(6):976-982. PubMed ID: 27514319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.
    Marquis-Gravel G; Boivin-Proulx LA; Huang Z; Zelenkofske SL; Lincoff AM; Mehran R; Steg PG; Bode C; Alexander JH; Povsic TJ
    J Am Heart Assoc; 2023 Jan; 12(1):e025666. PubMed ID: 36583436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between arterial access site and anticoagulation strategy on major bleeding and mortality: A historical cohort analysis in the Veteran population.
    Bagai J; Little B; Banerjee S
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):95-101. PubMed ID: 28624360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfemoral approach with systematic use of FemoSeal™ closure device compared to transradial approach in primary angioplasty.
    Alonzo A; Rigattieri S; Giovannelli F; Di Russo C; Sciahbasi A; Berni A; Volpe M
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):849-54. PubMed ID: 26104978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of radial, brachial, and femoral accesses using hemostatic devices for percutaneous coronary intervention.
    Otsuka M; Shiode N; Nakao Y; Ikegami Y; Kobayashi Y; Takeuchi A; Harima A; Higaki T; Oi K; Dai K; Kawase T; Nakama Y; Suenari K; Nishioka K; Sakai K; Shimatani Y; Masaoka Y; Inoue I
    Cardiovasc Interv Ther; 2018 Jan; 33(1):62-69. PubMed ID: 27830459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Rationale of the Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) Study.
    Behnes M; Ünsal M; Hoffmann U; Fastner C; El-Battrawy I; Lang S; Mashayekhi K; Lehmann R; Borggrefe M; Akin I
    Clin Med Insights Cardiol; 2015; 9():97-103. PubMed ID: 26568686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access site practice and procedural outcomes in relation to clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in the United kingdom.
    Ratib K; Mamas MA; Anderson SG; Bhatia G; Routledge H; De Belder M; Ludman PF; Fraser D; Nolan J;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):20-9. PubMed ID: 25616814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial.
    Rao SV; Hess CN; Barham B; Aberle LH; Anstrom KJ; Patel TB; Jorgensen JP; Mazzaferri EL; Jolly SS; Jacobs A; Newby LK; Gibson CM; Kong DF; Mehran R; Waksman R; Gilchrist IC; McCourt BJ; Messenger JC; Peterson ED; Harrington RA; Krucoff MW
    JACC Cardiovasc Interv; 2014 Aug; 7(8):857-67. PubMed ID: 25147030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular Closure Devices Attenuate Femoral Access Complications of Primary Percutaneous Coronary Intervention.
    Beraldo de Andrade P; de Ribamar Costa J; Rinaldi FS; de Castro Bienert IR; Barbosa RA; Esteves V; Tebet M; Zukowski C; Maia F; Piva E Mattos LA; Labrunie A; Abizaid A; Sousa AR
    J Invasive Cardiol; 2020 Oct; 32(10):364-370. PubMed ID: 32999089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Transradial PCI compared to Transfemoral PCI in veterans with anemia: Insight from the VA Clinical Assessment, Reporting and Tracking (CART) program.
    Bagai J; Hess E; Penny WF; Plomondon ME; Waldo SW
    Cardiovasc Revasc Med; 2019 Nov; 20(11):990-996. PubMed ID: 30679117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.
    Wimmer NJ; Secemsky EA; Mauri L; Roe MT; Saha-Chaudhuri P; Dai D; McCabe JM; Resnic FS; Gurm HS; Yeh RW
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003464. PubMed ID: 27059685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
    Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.